OPA1 Controls Apoptotic Cristae Remodeling Independently from Mitochondrial Fusion  by Frezza, Christian et al.
OPA1 Controls Apoptotic Cristae
Remodeling Independently
fromMitochondrial Fusion
Christian Frezza,1 Sara Cipolat,1 Olga Martins de Brito,1 Massimo Micaroni,2 Galina V. Beznoussenko,2
Tomasz Rudka,3 Davide Bartoli,1 Roman S. Polishuck,2 Nika N. Danial,4 Bart De Strooper,3 and Luca Scorrano1,*
1Dulbecco-Telethon Institute, Venetian Institute of Molecular Medicine, Padova, Italy
2Department of Cell Biology and Oncology, Consorzio ‘‘Mario Negri Sud,’’ Santa Maria Imbaro, Italy
3Neuronal Cell Biology and Gene Transfer Laboratory, Center for Human Genetics, Flanders Interuniversity Institute for
Biotechnology (VIB4) and K.U. Leuven, Belgium
4Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
*Contact: luca.scorrano@unipd.it
DOI 10.1016/j.cell.2006.06.025SUMMARY
Mitochondria amplify activation of caspases
during apoptosis by releasing cytochrome c
and other cofactors. This is accompanied by
fragmentation of the organelle and remodeling
of the cristae. Here we provide evidence that
Optic Atrophy 1 (OPA1), a profusion dynamin-
related protein of the inner mitochondrial mem-
brane mutated in dominant optic atrophy, pro-
tects from apoptosis by preventing cytochrome
c release independently from mitochondrial fu-
sion. OPA1 does not interfere with activation of
themitochondrial ‘‘gatekeepers’’ BAX andBAK,
but it controls the shape of mitochondrial cris-
tae, keeping their junctions tight during apopto-
sis. Tightness of cristae junctions correlates
with oligomerization of two forms of OPA1,
a soluble, intermembrane space and an integral
inner membrane one. The proapoptotic BCL-2
family member BID, which widens cristae junc-
tions, also disrupts OPA1 oligomers. Thus,
OPA1 has genetically and molecularly distinct
functions in mitochondrial fusion and in cristae
remodeling during apoptosis.
INTRODUCTION
Mitochondria amplify apoptosis induced by several stimuli
(Green and Kroemer, 2004). They release cytochrome c
and other proapoptotic proteins activating a postmito-
chondrial pathway that culminates in cell demise (Wang,
2001). Proteins of the BCL-2 family control the release of
cytochrome c from mitochondria required for the activa-
tion of effector caspases (Adams and Cory, 2001). The
‘‘BH3-only’’ proapoptotic members of the family transmitthe different apoptotic signals to the multidomain mem-
bers BAX and BAK that are required for cytochrome c re-
lease and mitochondrial dysfunction (Scorrano and Kors-
meyer, 2003). In a widely accepted model, these proteins
can form a channel for the efflux of cytochrome c across
the outer mitochondrial membrane (Green and Kroemer,
2004). Additional pathways downstream of the BH3-only
proteins ensure complete release of cytochrome c and mi-
tochondrial dysfunction. They include fragmentation of the
mitochondrial network and remodeling of the cristae char-
acterized by fusion of individual cristae and opening of the
cristae junctions (Frank et al., 2001; Scorrano et al., 2002).
Mitochondrial morphology is controlled by a growing
family of ‘‘mitochondria-shaping’’ proteins (Griparic and
van der Bliek, 2001). Mitofusin (MFN) -1 and -2 are dyna-
min-related proteins of the outer membrane (OM) essential
for mitochondrial tethering and fusion (Santel and Fuller,
2001; Legros et al., 2002; Santel et al., 2003; Chen et al.,
2003). MFN2 is presumed to have mostly a regulatory
role (Ishihara et al., 2004), while MFN1 tethers two juxta-
posed organelles (Koshiba et al., 2004) and cooperates
with Optic Atrophy 1 (OPA1) in the fusion process (Cipolat
et al., 2004). OPA1 is also a dynamin-related protein that
resides in the inner mitochondrial membrane (IM). Dyna-
min-related protein 1 (DRP-1) is located in the cytoplasm
but during fission translocates to mitochondria where it
binds to hFis1, its adaptor in the OM (Smirnova et al.,
2001; Yoon et al., 2003; James et al., 2003). It is presumed
that DRP-1 can sever both membranes either directly or by
recruiting other IM proteins.
A growing body of evidence suggests that mitochon-
dria-shaping proteins participate in cell death. Dnm1p,
the yeast ortholog of DRP-1, mediates mitochondrial
fragmentation and apoptosis-like death in S. cerevisiae
(Fannjiang et al., 2004). Blocking Drp-1 in C. elegans in-
hibits apoptotic mitochondrial fragmentation and results
in the accumulation of supernumerary cells during devel-
opment (Jagasia et al., 2005). Expression of a dominant
negative mutant of DRP-1 or downregulation of hFis1 inCell 126, 177–189, July 14, 2006 ª2006 Elsevier Inc. 177
mammalian cells delays cytochrome c release and apo-
ptosis (Frank et al., 2001; Lee et al., 2004). MFN1 and
MFN2, alone or in combination, prevent death by some in-
trinsic stimuli (Sugioka et al., 2004; Neuspiel et al., 2005),
consistent with early inhibition of MFN1-dependent fusion
during apoptosis (Karbowski et al., 2004). Following sev-
eral death stimuli, including the BH3-only proteins BID
and BIK, mitochondria remodel their internal structure: in-
dividual cristae fuse and cristae junctions widen, allowing
complete cytochrome c release (Scorrano et al., 2002;
Germain et al., 2005). While the molecular details of mito-
chondrial fragmentation during apoptosis have been par-
tially unraveled, little is known about the mechanisms con-
trolling cristae remodeling, and we wished to further
elucidate this process. OPA1 protects from apoptosis
and is so far the only mitochondria-shaping protein asso-
ciated with the IM (Olichon et al., 2003), making it a poten-
tial candidate to control cristae remodeling. Downregula-
tion of OPA1 not only causes mitochondrial fragmentation
but also alters the shape of the cristae (Olichon et al.,
2003). Since cristae contain the bulk of cytochrome c,
the regulation of this process could explain the known
antiapoptotic effect of OPA1. Alternatively, OPA1 could
act by counteracting mitochondrial fission (Lee et al.,
2004). Here we genetically dissect the role of OPA1 in ap-
optosis and find that this can be separated from its role in
mitochondrial fusion.
RESULTS
OPA1 Protects from Apoptosis by Preventing
Cytochrome c Release and Mitochondrial
Dysfunction
Expression of wild-type (wt) OPA1 protected mouse em-
bryonic fibroblasts (MEFs) from death induced by apopto-
tic stimuli that activate the mitochondrial pathway like
H2O2, etoposide, staurosporine, and truncated, active
BID (tBID) (Wei et al., 2001; Scorrano et al., 2003) (Figures
1A–1D). OPA1 did not affect the extrinsic pathway of apo-
ptosis recruited by TNFa since MEFs used in these exper-
iments behave like type I cells not safeguarded by expres-
sion of BCL-2 (not shown). In type I cells, death receptors
directly activate effector caspases, bypassing the mito-
chondrial amplificatory loop (Scaffidi et al., 1998). Muta-
tion of a conserved Lys of the GTPase domain to Ala
(OPA1K301A), or truncation of a part of the C-terminal
coiled-coil domain (OPA1R905*) impair OPA1 pro-fusion
activity (Cipolat et al., 2004). When these mutants were ex-
pressed at similar levels to wt OPA1 (data not shown and
Cipolat et al., 2004), they failed to protect from all the stim-
uli tested (Figure 1). Thus, the GTPase and the C-terminal
coiled-coil domains of OPA1 are required for protection
from apoptosis.
OPA1 delayed release of cytochrome c following H2O2
(Figure 2A; quantification in Figure 2B), staurosporine
(Figure S1B), etoposide, and tBID (not shown). Release
of cytochrome c is accompanied by mitochondrial dys-
function and loss of mitochondrial membrane potential.178 Cell 126, 177–189, July 14, 2006 ª2006 Elsevier Inc.We followed in real time changes in the mitochondrial fluo-
rescence of the potentiometric probe tetramethylrhod-
amine methylester (TMRM). OPA1 prevented depolariza-
tion induced by H2O2 (Figures 2C and 2D). Conversely,
OPA1K301A had no such protective effects on cytochrome
c release and mitochondria depolarization (Figures 2C
and 2D). These results indicate that functional OPA1 de-
creases release of cytochrome c and loss of mitochondrial
membrane potential during apoptosis.
OPA1 Does Not Require Mitofusins
to Protect from Apoptosis
OPA1 requiresMfn1 for its profusion activity (Cipolat et al.,
2004). To check whether OPA1 protects against apoptosis
by promoting fusion, we expressed OPA1 in MEFs lacking
Mfn1. OPA1 protected Mfn1/ cells from apoptosis in-
duced by all the intrinsic stimuli tested to an extent similar
to that observed in wt cells (Figures 3A–3C). Since residual
mitochondrial fusion is still observed in Mfn1/ MEFs, we
Figure 1. OPA1 Protects Against Apoptosis by Intrinsic
Stimuli
wt MEFs were cotransfected with GFP and the indicated plasmids and
after 24 hr treated with 1 mM H2O2 (A) (mean ± SEM of 12 independent
experiments), 2 mM etoposide (B) (mean ± SEM of 12 independent ex-
periments), or 2 mM staurosporine (C) (mean ± SEM of 12 independent
experiments) for the indicated times. In (D) cells were cotransfected
with GFP and pcDNA3.1 or with pcDNA3.1-tBID and after 24 hr viability
was determined. Data represent average ± SEM of 7–12 independent
experiments.
Figure 2. OPA1 Delays Release of Cyto-
chrome c and Mitochondrial Dysfunction
during Apoptosis
(A) Representative images of subcellular cyto-
chrome c distribution. wt MEFs were cotrans-
fected with mtRFP (red), and the indicated
plasmids were left untreated or treated for 30
min with 1 mM H2O2, fixed and immunostained
for cytochrome c (green). Bar, 15 mm.
(B) Localization index of cytochrome c. Exper-
iments were performed as in (A), but cells
were fixed at the indicated times. Data repre-
sent mean ± SEM of five independent experi-
ments.
(C) Pseudocolor-coded images of TMRM fluo-
rescence in wt MEFs cotransfected with GFP
and the indicated plasmids. Left images repre-
sent the initial frame of the real-time sequence,
while right ones were acquired at time = 40 min.
Asterisks indicate GFP-positive cells. The
pseudocolor scale is shown. Bar, 40 mm.
(D) Quantitative analysis of TMRM fluores-
cence changes over mitochondrial regions.
When indicated (arrows), 1 mM H2O2, and
2 mM FCCP were added. Data represent aver-
age ± SEM of eight independent experiments
performed as in (C).turned to cells doubly deficient for Mfn1 and Mfn2 (DMF),
where fusion is completely blocked (Chen et al., 2005).
DMF cells appeared as sensitive to staurosporine and
H2O2 as wt and singleMfn1
/ cells, and OPA1 was effec-
tive in protecting them from apoptosis (Figures 3D and
3E). We confirmed that OPA1 inhibited release of cyto-
chrome c in Mfn1/ and in DMF cells induced by H2O2
(Figures 3F and 3G) or by staurosporine (Figures S1C
and S1D). Of note, Mfn1/ and DMF mitochondria ex-
pressing OPA1 remained completely fragmented, yet
they retained cytochrome c, further dissociating blockage
of cytochrome c release from mitochondrial fusion. Thus,
OPA1 protects from apoptosis in the absence of MFN1
and MFN2. The profusion activity of OPA1 is therefore
not necessary for its antiapoptotic activity.OPA1 Controls Cytochrome c Mobilization
from Mitochondrial Cristae
We verified whether OPA1 influenced the release of cyto-
chrome c in an in vitro quantitative assay using purified or-
ganelles and recombinant proteins. Cytochrome c release
from mitochondria isolated from control MEF clones carry-
ing an empty vector with a Puromycin resistance gene
(wt::Puro and Mfn1/::Puro) in response to recombinant,
caspase-8-cleaved p7/p15 BID (cBID) was almost com-
plete after 15 min. We generated clones expressing high
levels of OPA1 (wt::Opa1 and Mfn1/::Opa1) as con-
firmed by immunoblotting (Figure S2). Mitochondria iso-
lated from these cells conversely retained a significant
fraction of cytochrome c even after 15 min (Figures 4A–
4D). Release was extremely fast in mitochondria isolatedCell 126, 177–189, July 14, 2006 ª2006 Elsevier Inc. 179
Figure 3. MitofusinsAreNot Required for
the Antiapoptotic Effect of OPA1
(A–E) Cells of the indicated genotype were co-
transfected with GFP and the indicated plas-
mids and treated with 1 mM H2O2 (A and D)
or 2 mM staurosporine (B and E). At the indi-
cated times, cells were harvested and viability
was determined. In (C), Mfn1/ MEFs were
cotransfected with GFP and pcDNA3.1 or
pcDNA3.1-tBID and after 24 hr viability was de-
termined. Data represent average ± SEM of ten
independent experiments.
(F) Representative images of subcellular cyto-
chrome c distribution. Cells of the indicated ge-
notype cotransfected with mtRFP (red) and the
indicated plasmid were left untreated or treated
for 30 min with 1 mM H2O2, fixed, and immuno-
stained for cytochrome c (green). Bar, 10 mm.
(G) Localization index of cytochrome c. Exper-
iments were performed as in (F), except that
cells were fixed at the indicated times. Data
represent average ± SEM of five independent
experiments.from MEFs expressing high levels of OPA1K301A (wt::
Opa1K301A) or a short hairpin RNA interference targeting
OPA1 (wt::shOpa1) (Figure S2), reaching85% of the total
pool of cytochrome c after only 5 min (Figures 4B and 4C).
Thus, levels of active OPA1 regulate the release of cyto-
chrome c from mitochondria. The final step of cytochrome
c release from mitochondria requires activation and oligo-
merization of the multidomain proapoptotic BCL-2 family
members BAX and BAK. We found that OPA1 did not de-
lay activation and translocation of BAX to mitochondria in180 Cell 126, 177–189, July 14, 2006 ª2006 Elsevier Inc.response to staurosporine (Figure S1A). Furthermore, BAK
activation, measured by its oligomerization in purified mi-
tochondria upon BID stimulation, was also unaltered (Fig-
ures 4F and 4G). Thus, OPA1 does not interfere with acti-
vation of proapoptotic members of the BCL-2 family,
crucial for the permeabilization of the OM.
A small fraction of cytochrome c, corresponding to
15%–20% of the total, is found free in the IMS, while
most is located in the cristae (Scorrano et al., 2002). The
OM of mitochondria can be selectively permeabilizedFigure 4. OPA1 Controls Mobilization of
Cytochrome c from Mitochondrial Cris-
tae in Response to BID
(A–D) Mitochondria isolated from MEFs of the
indicated genotype were treated for the indi-
cated times with cBID. After centrifugation the
amount of cytochrome c in supernatant and
pellet was determined by a specific ELISA.
Data represent average ± SEM of four indepen-
dent experiments.
(E) Mitochondria isolated from MEFs of the indi-
cated genotype were incubated with cBID for 3
min. The OM was then permeabilized with 40
pmol digitonin 3 mg1 mitochondria for 5 min.
After centrifugation, cytochrome c content in
supernatant and pellet was measured as in (A).
(F and G) wt (F) andMfn1/ (G) mitochondria of
the indicated genotype were treated with cBID
for the indicated times. DMSO or 10 mM BMH
was then added and after 30 min the crosslink-
ing reaction was quenched (Wei et al., 2000).
Equal amounts (40 mg) of mitochondrial pro-
teins were analyzed by SDS-PAGE/immuno-
blotting using anti-BAK antibody. Asterisks:
BAK multimers.
(H) Representative traces of ascorbate-driven respiration following BID treatment. Mitochondria of the indicated genotype were treated for 5 min with
cBID and then transferred into an oxygen electrode chamber. Where indicated (arrows), 6 mM ascorbate-Tris and 300 mM TMPD were added.
(I and J) Quantitative analysis of the effect of OPA1 levels and function on BID-induced cytochrome c mobilization. Mitochondria of the indicated ge-
notype were treated with cBID for 5 (I) or 3 min (J), and cytochrome c in the supernatant was assayed as in (D). Data represent average ± SEM of five
independent experiments.
Figure 5. Mitochondrial Morphological Changes in Response to BID: Regulation by OPA1
(A) Representative EM fields of mitochondria of the indicated genotype. Where indicated, mitochondria were treated for 5 min with cBID, except for
wt::shOpa1 and wt::Opa1K301A mitochondria, which were treated for 3 min. Arrows indicate class II mitochondria. Bar, 600 nm.
(B) Magnifications of representative transmission EM of mitochondria. Experiments were performed as in (A). Bar, 200 nm.
(C) Blind morphometric analysis of randomly selected EM fields of mitochondria of the indicated genotype. The experiments were performed as in (A).
Inset shows representative class I and class II (remodeled) morphologies (Scorrano et al., 2002). Data represent average ± SEM of three independent
experiments.using titrated amounts of digitonin to selectively release
the IMS pool of cytochrome c (Scorrano et al., 2002). Ap-
proximately 15% of total cytochrome c was released
upon permeabilization of the outer membrane in wt and
Mfn1/ mitochondria, irrespective of OPA1. When wt
and Mfn1/ mitochondria were pretreated with cBID for
3 min, 60% of total cytochrome c was recovered in the
supernatant, confirming that at this early timepoint cBID
promotes mobilization of cytochrome c from cristae to
the IMS (Scorrano et al., 2002). This increase in digitonin-
releasable cytochrome c upon cBID treatment was not ob-
served in mitochondria from cells expressing OPA1
(Figure 4E). Thus, OPA1 appears to selectively stabilize
the pool of cytochrome c that cBID mobilizes towards
the IMS.
We therefore measured cytochrome c mobilization from
cristae using a specific assay. Given the different redox
potential and accessibility of membrane bound and free
cytochrome c, these two pools can be specifically re-
duced by ascorbate and N,N,N0,N0-tetramethyl-p-phenyl-
enediamine (TMPD) (Scorrano et al., 2002; Nicholls et al.,
1980). The ratio of ascorbate over TMPD-driven O2 con-
sumption (asc/TMPD) therefore provides an estimate of
the pool of free cytochrome c in the IMS relative to the total
mitochondrial cytochrome c. An increase in asc/TMPD
ratio reflects the mobilization of cytochrome c from the
cristae stores towards the IMS (Scorrano et al., 2002).cBID almost doubled this ratio in wt and Mfn1/ mito-
chondria (Figures 4H and 4I). OPA1 did not affect basal
asc/TMPD ratio, but it blocked the increase in the ratio ob-
served upon cBID treatment in wt and Mfn1/ mitochon-
dria (Figures 4H and 4I). Conversely, OPA1K301A and
downregulation of OPA1 levels augmented the effect of
cBID on the asc/TMPD ratio (Figure 4J). Of note, lower
OPA1 levels resulted in a small but significant increase
in basal asc/TMPD ratio (Figure 4J, p < 0.05 compared
to control wt::Hygro mitochondria). Thus, OPA1 regulates
apoptotic redistribution of cytochrome c from the cristae.
OPA1 Controls Apoptotic Remodeling
of Mitochondrial Cristae
The changes in mitochondrial ultrastructure defined as
‘‘cristae remodeling’’ correlate with redistribution of cyto-
chrome c from the cristae (Scorrano et al., 2002). Using
conventional transmission electron microscopy (TEM), it
is possible to identify remodeled ‘‘class II’’ mitochondria
and normal ‘‘class I’’ mitochondria based on the appear-
ance of the electron transparent cristae (see Figure 5C
for representative images). We therefore turned to TEM
of mitochondria isolated from the generated cellular
models to investigate whether OPA1 influenced remodel-
ing of the cristae. OPA1 promoted juxtaposition of the cris-
tae membranes, generating extremely narrow structures
not seen in control mitochondria (Figures 5A and 5B).Cell 126, 177–189, July 14, 2006 ª2006 Elsevier Inc. 181
In contrast, cristae appeared wider and in wt::Opa1K301A
and wt::shOpa1 mitochondria (Figures 5A and 5B).
Mfn1/::Puro andMfn1/::Opa1mitochondria displayed
hyperconvex, balloon-like cristae, connected by narrow,
tubular, elongated junctions to the intermembrane space
(Figures 5A and 5B). cBID induced the appearance of
several class II organelles in control populations (arrows
in Figure 5A; magnification in Figure 5B). These remodeled
mitochondria were predominant in wt::Opa1K301A or
wt::shOpa1 as soon as 3 min after cBID (arrows in Figure
5A; magnification in Figure 5B). On the other hand, cristae
of wt::Opa1 and Mfn1/::Opa1 mitochondria remained
narrow, and mainly class I mitochondria were retrieved
following cBID (Figure 5A; magnification in Figure 5B).
These observations were further corroborated by a mor-
phometric analysis (Figure 5C).
The effect of OPA1 on mitochondrial morphology and re-
modeling warranted a more detailed structural investiga-
tion by electron tomography. Cristae of wt::Puro mito-
chondria appeared as pleomorphic individual structures
connected to the IMS by a narrow tubular junction of
16.2 ± 2.1 nm (n = 9 in two different tomograms). wt
OPA1 promoted close juxtaposition of the cristae mem-
branes, and some cristae spanned the diameter of the
reconstructed mitochondrion. The cristae junction was
extremely narrow, measuring 15.2 ± 2.3 nm (n = 9 in two
different tomograms) (Figure 6A). Conversely, wt::
Opa1K301A and wt::shOpa1 cristae protruded in the matrix
for less than the radius of the organelle. The narrow tubular
junction was unaltered in wt::Opa1K301A (17.1± 2.1 nm, n =
9 in two different tomograms) and in wt::shOpa1mitochon-
dria (20.2 ± 1.6 nm, n = 9 in two different tomograms)
(Figure 6A).
In wt::Puro mitochondria cBID promoted fusion of cris-
tae in few intercommunicating compartments and wid-
ened the cristae junctions (45.4 ± 3.2 nm, n = 9 in two dif-
ferent tomograms). In wt::Opa1 mitochondria, in contrast,
cristae fused following cBID, but they retained an ex-
tremely narrow aspect, and the diameter of the tubular
junction remained small (20.2 ± 3.1 nm, n = 9 in two differ-
ent tomograms). Cristae junction diameter increased ex-
tremely in wt::Opa1K301A mitochondria (65.3 ± 4.2 nm,
n = 9 in two different tomograms) and in wt::shOpa1
(73.3 ± 2.1 nm, n = 9 in two different tomograms)
(Figure 6A). Rotation of a volume-rendered 3D reconstruc-
tion where the outer membrane had been peeled out
allowed clear visualization of the cristae junctions (Fig-
ure 6B). In untreated mitochondria, these narrow struc-
tures were unaffected by expression of OPA1. Following
cBID they became greatly enlarged, and this enlargement
was entirely prevented by OPA1 expression (Figure 6B).
To investigate whether OPA1 required Mfn1 to control
shape and remodeling of the cristae, we turned to
Mfn1/ mitochondria. Mfn1/::Puro mitochondria
showed balloon-like, hyperconvex, individual cristae co-
existing with more conventional pleomorphic ones. Inde-
pendently from their shape, cristae had narrow junctions
of 19.0 ± 2.1 nm (n = 9 in two different tomograms).182 Cell 126, 177–189, July 14, 2006 ª2006 Elsevier Inc.Mfn1/::Opa1 mitochondria showed balloon cristae with
some aspects of close juxtaposition of cristae membranes
similar to those observed in wt::Opa1 organelles. The nar-
row tubular junction of these cristae measured 18.3 ± 2.2
nm (n = 9 in two different tomograms). cBID caused fusion
of Mfn1/::Puro cristae and widening of their tubular
junctions (41.4 ± 2.2 nm, n = 9 in two different tomograms).
Conversely, junctions remained tight in Mfn1/::Opa1
cristae, their diameter measuring 18.5 ± 2.0 nm (n = 9 in
two different tomograms) (Figure 6A). Thus, OPA1 coun-
teracts the widening of the tubular junctions induced by
cBID independently of MFN1.
Oligomers of Soluble and Membrane Bound OPA1
Are Disrupted by BID Early during Apoptosis
We turned to a biochemical approach to determine how
OPA1 could control cristae shape. OPA1 is synthesized
as an integral IM protein from one single gene. Alternative
splicing generates eight different transcripts, all of them
containing the transmembrane domain (Delettre et al.,
2001), but a minor fraction of OPA1 is released in the
IMS in a process that is regulated by the IM rhomboid pro-
tease PARL (Cipolat et al, 2006). The IMS form is crucial for
OPA1 antiapoptotic activity (Cipolat et al., 2006). We ver-
ified whether expression of OPA1 in wt and Mfn1/ cells
resulted in an increase in IMS OPA1. Immunoblotting of
membrane (pellet) and IMS (supernatant) fractions gener-
ated by hypotonic swelling and salt washes of mitochon-
dria revealed that following expression, levels of IMS
OPA1 were increased (Figure 7A). OPA1 in the mem-
brane-enriched fraction was resistant to carbonate ex-
traction, further indicating that this OPA1 form is integrally
inserted in the IM (not shown). Consistent with this, only
a minor fraction of OPA1 was released from mitochondria
treated with cBID, even when cytochrome c release was
complete (Figure S3). Thus, complete release of OPA1
does not occur in isolated mitochondria upon cBID treat-
ment and can therefore not explain cristae remodeling, as
previously suggested (Arnoult et al., 2005).
We therefore analyzed in greater detail OPA1 in normal
and apoptotic mitochondria. Percoll-purified normal and
cBID-treated, CHAPS-solubilized mouse liver mitochon-
dria displayed very similar elution patterns from Superose
6 columns (not shown) (Danial et al., 2003). Fractions were
pooled according to their size exclusion properties, desig-
nated B to E4 in descending order of molecular weight, and
analyzed by SDS-PAGE and immunoblot. OPA1 was re-
vealed in the high-molecular-weight fractions B to E2, indi-
cating that OPA1 was part of a multimolecular complex.
The matrix protein cyclophilin D used as a control was
found only in fractions E3 and E4. Another OPA1 immuno-
reactive band with a MW corresponding to that of the sol-
uble IMS form (Figure 7A) was found in fractions E2 (180–
230 kDa), E1 (230–440 kDa), and D (440–670 kDa),
indicating that IMS OPA1 is also part of a multiprotein com-
plex (Figure 7B). Following cBID, OPA1 was retrieved in
fractions D, E2, and E3. p15 fragment of BID was specifi-
cally enriched in this last fraction and to a lower extent in
Figure 6. Electron Tomography of Mitochondrial Morphological Changes in Response to BID: Regulation by OPA1
(A) Surface-rendered views of tomographic reconstructions of mitochondria of the indicated genotype. Where indicated, mitochondria were treated
with cBID for 5 min before fixation. wt::shOpa1 and wt::Opa1K301A mitochondria were treated for 3 min. Outer membrane is depicted in light gray, inner
boundary membrane in red, and cristae in green. Cyan arrowheads point to cristae junctions. Note that selected, representative cristae were traced
when their degree of interconnectivity allowed it.
(B) Rotations of representative surface rendered views of tomographic reconstructions of mitochondria. Experiment was as in (A). Cristae are
depicted in purple and inner boundary membrane in orange. Outer membrane has been peeled out to highlight individual openings of the cristae
junctions (arrowheads).Cell 126, 177–189, July 14, 2006 ª2006 Elsevier Inc. 183
Figure 7. Oligomers Comprising IMS and Transmembrane OPA1 Are Early Targets of BID
(A) Mitochondria of the indicated genotype were hypotonically swollen and membrane (p) and soluble (intermembrane space, s) fractions were
recovered. Proteins were separated by SDS-PAGE and immunoblotted with the indicated antibodies. COX indicates cytochrome c oxidase III.184 Cell 126, 177–189, July 14, 2006 ª2006 Elsevier Inc.
fractions D, C, and E4. The matrix protein cyclophilin D was
selectively enriched in low MW fraction E4 (Figure 7B).
Thus, OPA1 is mainly found in high MW complexes; the
lower MW form of OPA1, corresponding to IMS OPA1, is
specifically enriched in fractions D to E2; and OPA1 is
mainly found in lower MW fractions in apoptotic mitochon-
dria, corresponding to smaller protein complexes.
Dynamin-related proteins are known to homo-hetero
oligomerize (Danino and Hinshaw, 2001). We asked
whether OPA1 could also form oligomers containing IMS
and/or transmembrane forms. Such a structure could rep-
resent a molecular staple that juxtaposes the cristae
membranes and could participate in the formation of the
narrow tubular junction (Figure 7C). We tested whether
chemical crosslinking revealed higher-order complexes
immunoreactive for OPA1. A complex of OPA1 of 290
kDa was indeed identified in mitochondria treated with
the zero-length crosslinker 1-ethyl-3-(3-dimethylamino-
propyl)carbodiimide (EDC) (Figure 7D). Identical results
were observed with the 16 A˚ crosslinker bismaleimidohex-
ane (not shown). This complex was absent in mitochon-
dria whose cristae had been mechanically distended by
osmotic swelling (asterisk in Figure 7D). Thus, OPA1 can
be crosslinked into a high-order complex only when cris-
tae are intact. In order to understand the composition of
this complex, we turned to Parl/ mitochondria where
IMS OPA1 is greatly reduced (Cipolat et al., 2006). Levels
of OPA1 complex were also reduced, suggesting a role for
IMS OPA1 in its formation (Figure 7H). A FLAG-tagged ver-
sion of OPA1 selectively targeted to the IMS (IMS-OPA1-
FLAG) (Otera et al., 2005; Cipolat et al., 2006) expressed in
Parl/ mitochondria was retrieved in the EDC-cross-
linked complex by specific anti-FLAG immunoblotting
(asterisk in Figure 7E). Reprobing of the membrane with
an anti-OPA1 antibody revealed that IMS-OPA1-FLAG
displayed an apparent MW of 88 kDa (arrowhead in
Figure 7E), while endogenous OPA1 run at 100 kDa.
Following crosslinking, levels of 100 kDa endogenous and
of 88 kDa IMS-OPA1-FLAG were decreased, while the
levels of the larger complex increased, suggesting that
both IMS and transmembrane forms of OPA1 constitutean oligomer. We further tested this by coexpressing a
His-tagged version of OPA1 (OPA1-6His) with IMS-OPA1-
FLAG in Parl/ MEFs. As expected, 98% of OPA1-6His
remained transmembrane in mitochondria lacking PARL,
as judged by immunoblotting of membrane and IMS frac-
tions (not shown). Transmembrane OPA1-6His and IMS
OPA1-FLAG were both found in the oligomer by specific
immunoblotting (Figure 7F). Thus, the oligomer contains
both transmembrane and IMS OPA1.
We next assessed the fate of this OPA1 oligomer during
apoptosis. The oligomer rapidly disappeared following
cBID, becoming almost undetectable after 5 min (Figures
7G and 7H). Expression of OPA1 augmented levels of
this oligomer and, more importantly, stabilized it in cBID-
treated mitochondria (Figure 7G). In Parl/ mitochondria
with greatly reduced IMS-OPA1 (Cipolat et al., 2006),
OPA1 oligomer was weakly represented and early disrup-
ted by cBID (Figure 7H). A quantitative, densitometric anal-
ysis confirmed faster disappearance of the oligomer in
Parl/mitochondria and its stabilization following expres-
sion of OPA1 in wt organelles (Figure 7I). Of note, destabi-
lization of OPA1 oligomer is an initial event following cBID,
occurring before the complete release of cytochrome c.
In as early as 5 min, levels in the oligomer are reduced
by70%. This almost complete destabilization correlates
with the release of approximately 80% of the cytochrome c
observed at the same timepoint (Figure 4A). OPA1 oligo-
mer is therefore an early target during cytochrome c re-
lease induced by BID. Expression of IMS-OPA1-FLAG
protected Parl/ MEFs from apoptosis (Cipolat et al.,
2006) and prevented the enhanced cristae remodeling ob-
served in response to cBID (Figure S4), substantiating the
role of OPA1 oligomerization in this pathway.
DISCUSSION
The initial assumption that mitochondrial structure is
not affected during apoptosis has been challenged dur-
ing the last years. Mitochondrial fragmentation (Frank
et al., 2001; Jagasia et al., 2005) and cristae remodeling
(Scorrano et al., 2002; Germain et al., 2005) augment(B) Mouse liver mitochondria were treated when indicated with cBID for 10 min, solubilized in 6 mM CHAPS, and subjected to gel filtration on Super-
ose 6, and fractions were collected according to the indicated size exclusion properties, pooled, and concentrated. Fifty micrograms of proteins from
the indicated fractions were separated by SDS-PAGE and immunoblotted with the indicated antibodies. CypD indicates cyclophilin D.
(C) Cartoon depicting the effect of BID-induced cristae remodeling on putative OPA1 oligomers; OM and IM indicate outer and inner mitochondrial
membrane.
(D) Mitochondria left untreated or osmotically swollen for 10 min were incubated with 10 mM EDC for 30 min followed by centrifugation. Proteins in the
pellets were separated by SDS-PAGE and immunoblotted using anti-OPA1 antibodies; the asterisk indicates OPA1 oligomer.
(E) Mitochondria were isolated fromParl/MEFs transfected with IMS-OPA1-FLAG and treated with the crosslinker EDC as in (D). Proteins were sep-
arated by SDS-PAGE and immunoblotted using the indicated antibodies; arrows indicate IMS-OPA1-FLAG, while asterisks denote OPA1 oligomer.
(F) Parl/ MEFs were cotransfected with GFP and where indicated with IMS-OPA1-FLAG and OPA1-6His, sorted, and mitochondria were isolated.
Where indicated, mitochondria were treated with EDC as in (D). Equal amounts of protein were separated by SDS-PAGE and immunoblotted using the
indicated antibodies. Arrows indicate IMS-OPA1-FLAG and OPA1-6His, while asterisks denote OPA1 oligomer.
(G and H) Mitochondria of the indicated genotype were treated with cBID for the indicated times and then crosslinked with EDC as in (D). Proteins were
separated by SDSPAGE and immunoblotted using the indicated antibodies. Asterisk denotes OPA1 oligomer. Arrow indicates nonoligomerized
OPA1. COX is cytochrome c oxidase III.
(I) Kinetics of OPA1 oligomer destabilization by cBID. OPA1 oligomer was analyzed by densitometry on Immunoblots following normalization for load-
ing based on levels of COX. Data were normalized to levels of OPA1 oligomer in untreated mitochondria and represent average ± SEM of five inde-
pendent experiments.Cell 126, 177–189, July 14, 2006 ª2006 Elsevier Inc. 185
cytochrome c release and complete the program of mito-
chondrial dysfunction (Green and Kroemer, 2004). Little
is known about the molecular mechanisms behind this re-
modeling process, but a likely candidate protein is OPA1,
a dynamin-related protein of the IM, which mediates fusion
of the organelle. We demonstrate here that mitochondrial
remodeling and cytochrome c mobilization are regulated
by levels of functional OPA1 and that this occurs indepen-
dently from mitochondrial fusion. We also show that IMS
and transmembrane OPA1 form oligomers that are early
targets of BID during cristae remodeling.
OPA1 reduces cytochrome c release, mitochondrial
dysfunction, and cell death induced by intrinsic stimuli
without interfering with activation of the mitochondrial
gatekeepers, the multidomain proapoptotics BAX and
BAK (Scorrano and Korsmeyer, 2003). Given its function
in mitochondrial fusion, one could predict that OPA1 pro-
tects by counteracting apoptotic fragmentation of mito-
chondria, a process observed in several paradigms of
cell death (Youle and Karbowski, 2005). This appeared
not to be the case since OPA1 efficiently protects cells
lacking Mfn1, essential for OPA1-mediated mitochondrial
fusion (Cipolat et al., 2004), and doubly Mfn null MEFs
where fusion is completely abolished (Chen et al., 2005).
Active OPA1 on the other hand blocks intramitochondrial
cytochrome c redistribution that follows cristae remodel-
ing (Scorrano et al., 2002; Germain et al., 2005). Previous
approaches using conventional EM of mitochondria in
cells with downregulated OPA1 or mgm1p (its yeast homo-
log) showed a gross disruption of the overall cristae mor-
phology (Olichon et al., 2003; Amutha et al., 2004; Griparic
et al., 2004). Loss of mitochondrial DNA and therefore of
components of the respiratory chain contributed to this
phenotype in yeast (Amutha et al., 2004). In mammalian
cells, the remodeling of the cristae observed in situ can fol-
low the activation of apoptosis caused by ablation ofOpa1
(Olichon et al., 2003). We therefore reinvestigated the role
of OPA1 in biogenesis and remodeling of the cristae using
tomography of mitochondria isolated from cellular models
with defined levels of this protein. Electron tomography
showed that OPA1 regulates shape and length of mito-
chondrial cristae and more importantly cristae remodeling
during apoptosis. OPA1 keeps tight the cristae junction,
which is likely to regulate mobilization of cytochrome c to
the IMS following BID treatment.Mfn1/cristae appeared
hyperconvex. Nevertheless, they were still connected by
a narrow tubular junction to the IMS, and this junction wid-
ened following BID treatment. OPA1 did not change curva-
ture of Mfn1/ cristae but, significantly, blocked enlarge-
ment of the cristae junction. Thus, curvature of the cristae
is not the determining factor in cytochrome c release.
How does OPA1 regulate remodeling of the cristae?
One possibility is that OPA1 is released completely during
apoptosis, as it has been previously reported (Arnoult
et al., 2005). On the other hand, OPA1 has been found
to be mainly an integral IM protein (Griparic et al., 2004;
Satoh et al., 2003). We indeed observed the release of
only a small pool of OPA1 corresponding to a fraction of186 Cell 126, 177–189, July 14, 2006 ª2006 Elsevier Inc.the protein that is present in the IMS of untreated mito-
chondria. OPA1 exists in multiple splicing variants. Never-
theless, a transmembrane domain is present in all eight
different variants and ensures integral insertion in the IM.
So, how is this IMS pool of OPA1 produced? In yeast,
pcp1p/rbd1p, a rhomboid protease of the IM, cleaves
the transmembrane domain of mgm1p, the yeast homolog
of OPA1, to generate a short form soluble in the IMS
(McQuibban et al., 2003; Herlan et al., 2003). In an accom-
panying manuscript, evidence is provided that formation
of IMS OPA1 in mammalian mitochondria appears to de-
pend on PARL, the ortholog of rbd1p. Parl is also a prereq-
uisite for the antiapoptotic function of OPA1 (Cipolat et al.,
2006). This correlates with decreased levels of soluble
IMS OPA1 and can be rescued by IMS OPA1 expression
(Cipolat et al., 2006). We therefore investigated the poten-
tial role of IMS OPA1 at the molecular level. An indication
came from studies on dynamin I, which tubulates mem-
branes and assembles in oligomers that are crucial to
sever membranes (Sweitzer and Hinshaw, 1998). OPA1
is, however, located inside the bilayer on which it should
act. It therefore was unlikely that OPA1 could operate in
a similar way as dynamin I. We therefore tested an alterna-
tive hypothesis in which transmembrane OPA1 uses the
soluble, IMS form to oligomerize. These oligomers could
‘‘staple’’ the membranes of the cristae. We found support
for this hypothesis in a series of experiments. First, gel fil-
tration chromatography showed that OPA1 was found in
fractions containing high MW complexes (also in HeLa mi-
tochondria [Satoh et al., 2003]). Second, cBID destabilized
these oligomers, correlating with increased cytochrome c
release and apoptosis. Third, chemical crosslinking iden-
tified an 290 kDa OPA1 immunoreactive band that dis-
appeared when membranes of cristae were separated
by osmotic swelling. This oligomer contained the soluble
IMS form and the transmembrane IM form of OPA1, as
demonstrated using tagged versions of IMS and IM
OPA1. Fourth, the presence and disappearance of this
oligomer correlates with protection against and induction
of apoptosis and cytochrome c release, respectively.
Fifth, levels of IMS OPA1 are crucial for the formation of
the oligomer to protect from apoptosis (Cipolat et al.,
2006) and to prevent cristae remodeling. Taken together,
these results suggest that OPA1 oligomers participate in
formation and maintenance of the cristae junction.
The size of the OPA1 oligomer as determined by cross-
linking and the retrieval of tagged versions of IMS and IM
OPA1 in this oligomer suggest the hypothesis of at least
a trimer comprising two IM and one IMS OPA1. However,
OPA1 is also found in fractions of higher MW in both nor-
mal and apoptotic mitochondria. Thus, we cannot exclude
the possibility that other proteins participate in this com-
plex. The fact that we found OPA1 in a 230 to 180
kDa fraction following treatment with cBID would indeed
suggest that OPA1 can associate with other proteins dur-
ing apoptosis. This is a next challenge requiring copurifi-
cation experiments and proteomic approaches in normal
and apoptotic mitochondria.
Our work shows that OPA1 is a bifunctional protein. On
one hand it in promotes mitochondrial fusion, depending
on MFN1. On the other, it regulates apoptosis by control-
ling cristae remodeling and cytochrome c redistribution.
This correlates with OPA1 oligomerization and is depen-
dent on its cleavage by PARL. In conclusion, oligomeriza-
tion of OPA1 appears to be a mechanism that regulates
apoptosis by maintaining the tightness of cristae junc-
tions. This unexpected role of OPA1 needs to be further
explored. This mechanism could, for example, contribute
to the pathogenesis of dominant optic atrophy since mu-
tations causing this disease cluster in the GTPase and
coiled-coil domains of OPA1, possibly impairing assembly
and/or function of the OPA1 oligomer.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, Sorting, and Generation of Stable
Clones
SV40 transformed wt andMfn1/ MEFs were cultured as described in
Cipolat et al. (2004); DMF MEFs were cultured as described in Chen
et al. (2005). Cells were transfected using Transfectin (Biorad) following
manufacturer’s instructions.
For sorting, 13 108 cotransfected MEFs were analyzed by light for-
ward and side scatter and for GFP fluorescence through a 530 nm
band pass filter as they traversed the beam of an argon ion laser
(488 nm, 100 mW) of an FACSAria (BD). Nontransfected MEFs were
used to set the background fluorescence. Sorted cells were checked
for viability by Trypan Blue exclusion.
The single clones were generated by limited dilution following trans-
fection and antibiotic selection of expressing cells.
Analysis of Cell Death
1 3 105 MEFs of the indicated genotype grown in 12-well plates were
cotransfected with pEGFP and the indicated vector. After 24 hr cells
were treated as described and stained with Annexin-V-Alexa568
(Roche) according to manufacturer’s protocol. Apoptosis was mea-
sured by flow cytometry (FACSCalibur) as the percentage of an-
nexin-V-positive events in the GFP-positive population.
Transmission Electron Microscopy, Tomographic
Reconstruction, and Mitochondrial Morphometry
Mitochondria were fixed for 1 hr at 25ºC using glutaraldehyde at a final
concentration of 2.5% (V/V). Thin sections were imaged on a Tecnai-12
electron microscope (Philips-FEI) at the Telethon EM Core Facility
(TeEMCoF, Istituto Mario Negri Sud). For tomography, colloidal gold
particles were applied to one side of 200 nm-thick sections as align-
ment markers. Tilt series of 122 images were recorded around one tilt
axis, over an angular range of 120º with a 1º tilt interval. Images were
aligned and reconstructed as previously described (Scorrano et al.,
2002). The reconstructed volumes had dimensions of 512 3 512 3
80–100 pixels depending on section thickness, with a pixel size range
of 2.5–4.1 nm. Surface-rendered models were produced using IMOD
(Mironov et al., 2001) or Reconstruct (Fiala, 2005). Measurements
were made directly on 1 pixel-thick tomogram slices.
Molecular Biology
p3 3 FLAG-CMV14-AIF-Opa1 (IMS-OPA1-FLAG) and pCDNA3-
OPA1-HA-HisTag (OPA1-6His) were kind gifts from K. Mihara (Kyushu
University, Fukuoka, Japan) and P. Belenguer (U. of Toulouse, France),
respectively. shRNAi were constructed to target the nucleotide region
1813–1831 of murine OPA1. All other plasmids are described in Cipolat
et al. (2004).Imaging
For cytochrome c immunolocalization, cells grown on coverslips were
transfected with mtRFP and after 24 hr incubated as detailed. Immu-
nostaining for cytochrome c was performed as described in Scorrano
et al. (2003). For cytochrome c and mtRFP detection, green and red
channel images were acquired simultaneously using two separate
color channels on the detector assembly of a Nikon Eclipse E600 mi-
croscope equipped with a Biorad MRC-1024 laser scanning confocal
imaging system. The localization index was calculated as described in
Petronilli et al. (2001).
For imaging of mitochondrial membrane potential, MEFs grown on
coverslips were cotransfected as indicated and after 24 hr loaded with
10 nM TMRM (Molecular Probes) in the presence of 2 mg/ml cyclospor-
ine H, a P-glycoprotein inhibitor (30 min at 37ºC). Clusters of GFP-pos-
itive cells were identified and sequential images of TMRM fluorescence
were acquired every 30 s using an Olympus IMT-2 inverted micro-
scope equipped with a CellR Imaging system.
Recombinant Proteins
p7/p15 recombinant BID was produced, purified, and cleaved with
caspase-8 as described in Scorrano et al. (2002). Unless noted, it
was used at a final concentration of 32 pmol 3 mg1.
In Vitro Mitochondrial Assays
Mitochondria were isolated by standard differential centrifugation in
isolation buffer (IB). Oxygen consumption of mitochondria incubated
in experimental buffer (EB) was measured using a Clarke-type oxygen
electrode (Hansatech Instruments) (Scorrano et al., 2002). Cytochrome
c redistribution and release in response to recombinant cBID was
determined as described in Scorrano et al. (2002).
Biochemistry
For protein crosslinking, mitochondria were treated with 10 mM BMH
(Pierce) or with 10 mM EDC (Pierce) for 30 min at 37ºC. Samples
were centrifuged for 10 min at 120003 g at 4ºC, and the mitochondrial
pellets were resuspended in SDS-PAGE sample loading buffer. DTT in
the sample buffer quenched the crosslinking reaction. Proteins were
separated by 3%–8% Tris-Acetate or 4%–12% Tris-MES SDS-PAGE
(NuPage, Invitrogen), transferred onto PVDF membranes (Millipore),
and probed using the indicated primary antibodies and isotype
matched secondary antibodies conjugated to horseradish peroxidase.
Signals were detected using ECL (Amersham). Details on the anti-
bodies used can be found in Supplemental Data. Densitometry was
performed using a GS170 Calibrated Imaging densitometer, and data
were analyzed using Quantity One software (Biorad).
For Superose 6 filtration, purified mouse liver mitochondria (50 mg)
were solubilized in the presence of 6 mM CHAPS passed onto a Super-
ose 6 column, and fractions were collected, pooled, and concentrated
as described (Danial et al., 2003).
Additional details on the experimental procedures can be found in
Supplemental Data available with this article online.
Supplemental Data
Supplemental Data include four figures and can be found with this
article online at http://www.cell.com/cgi/content/full/126/1/177/DC1/.
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